Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target.
Janne W BoltCaroline J AalbersLaura WaletLeonieke J J van MensChristiaan van DenderenIrene van der Horst-BruinsmaLisa G M van BaarsenRobert LandewéMarleen G H van de SandePublished in: Rheumatology (Oxford, England) (2023)
This study shows that physicians do not always strictly apply treat-to-target in case of residual disease activity in axial spondyloarthritis. Usually, they accept low disease activity as satisfactory.